COVID@Home: cardiovascular disease and risk in non-hospitalized Covid-19 patients
- Conditions
- COVID@Home10028593
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Participants of the Rotterdam Study who recovered from a Covid-19 infection at
home.
Participants with prior known myocardial infarction (based on the information
previously collected within the Rotterdam Study from the GP registries) and/or
eGFR < 30 ml/min (based on the results acquired in previous rounds of the
Rotterdam Study), will be excluded from this study.
Subjects who meets any of the following criteria will be excluded from
undergoing the CMR: *
- Known contra-indications for CMR (e.g.: severe claustrophobia, metal
implants, severe renal failure)
- (e)GFR < 30 ml/min
- Known allergy for contrast
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Cardiac MRI parameters</p><br>
- Secondary Outcome Measures
Name Time Method <p>Parameters for cardiac structure en function.<br /><br><br /><br>Also:<br /><br>- Blood makers, including lipids (total cholesterol, HDL-cholesterol and<br /><br>triglycerides), glucose, CRP, Creatinine, Troponin I or T, NT-proBNP)<br /><br>- Data collected from questionnaires, e.g. covid-related symptoms and fatigue<br /><br>- Cardiovascular risk factors<br /><br><br /><br>Other study parameters:<br /><br><br /><br>Sleep and activity:<br /><br>- Sleep (Total sleep time, Sleep onset latency, Wake after sleep onset, Sleep<br /><br>efficiency)<br /><br>- 24-hour activity rhythms (Interdaily stability, Intradaily variability, Onset<br /><br>lowest hours of activity)<br /><br>- Mental health</p><br>